Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Neeraj N, Iyer"'
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 6, Pp 1035-1045 (2020)
Abstract Background Recurrent joint bleeding in hemophilia results in arthropathy and functional impairment. The relationship of arthropathy development and factor activity (FA) has not been reported in patients with FA levels 10% less than controls;
Externí odkaz:
https://doaj.org/article/cb85d5a24d044b8196e2e02c0a2aa953
Autor:
Lisa Bailey-Davis, James T. Dove, Neela Kumar, Neeraj N. Iyer, Jacob Mowery, Christopher D. Still, Abhilasha Ramasamy, G. Craig Wood, Adam Cook, B. Gabriel Smolarz, Peter N. Benotti
Publikováno v:
The American Journal of Cardiology. 162:66-72
Obesity increases the risk of developing type 2 diabetes, hypertension, and hyperlipidemia. We sought to determine the impact of obesity maintenance, weight regain, weight loss maintenance, and magnitudes of weight loss on future risk and time to dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa7cab2cfe25fa3786c8c588e6baf3ee
https://doi.org/10.1016/j.amjcard.2021.09.018
https://doi.org/10.1016/j.amjcard.2021.09.018
Autor:
Neeraj N. Iyer, Janine Bauman, Robert S. Zimmerman, Galen Miller-Atkins, B. Gabriel Smolarz, Anita D. Misra-Hebert, Bartolome Burguera, Kevin M. Pantalone, Arshiya Mariam, Michael W. Kattan, Daniel M. Rotroff, Todd Hobbs, Abhilasha Ramasamy, Alex Milinovich, Michelle Mocarski
Publikováno v:
Diabetes, Obesity and Metabolism. 23:2804-2813
Aims Little is known about the impact of weight loss on developing comorbidities in patients with obesity in real-world settings. Understanding health benefits and associated comorbidities with weight loss are critical to addressing the global obesit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::819414c2302a88713d8d91e780ae2d0f
https://doi.org/10.1111/dom.14538
https://doi.org/10.1111/dom.14538
Autor:
Neeraj N, Iyer, Surbhi, Shah, Michael L, Ganz, Tam, Dang-Tan, Cory, Gamble, Sherif, Mehanna, George, Bakris
Publikováno v:
The American journal of managed care. 28(8)
Recent trials of glucose-lowering drugs (GLDs) have drawn attention to renal outcomes. Our goal was to understand how patients with diabetic kidney disease (DKD) are treated in general practices in the United States.Retrospective cohort study using a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f4e29002abec0919ffd6a48ff5c8850a
https://pubmed.ncbi.nlm.nih.gov/35981131
https://pubmed.ncbi.nlm.nih.gov/35981131
Publikováno v:
ClinicoEconomics and Outcomes Research. 12:555-566
Objective Weight reduction is a key component of diabetes management in adults with type 2 diabetes mellitus (T2DM), yet the benefits of weight loss in T2DM patients have been difficult to quantify. We examined the medical literature regarding the re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f80571dccc63a766bf703d256026bb63
https://doi.org/10.2147/ceor.s266873
https://doi.org/10.2147/ceor.s266873
Autor:
Todd Hobbs, Amit D. Raval, Jonathan Bouchard, Jay Visaria, David M. Kern, Neeraj N. Iyer, Vincent J. Willey, Sheldon X. Kong
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Jay Visaria,1 Neeraj N Iyer,2 Amit D Raval,3 Sheldon X Kong,2 Todd Hobbs,2 Jonathan Bouchard,2 David M Kern,4 Vincent J Willey1 1HealthCore, Inc., Wilmington, DE, USA; 2Novo Nordisk, Inc., Plainsboro Township, NJ, USA; 3Merck & Co., Inc, Kenilworth,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee89de1c80d72dd5031a74017128eaae
http://europepmc.org/articles/PMC7428320
http://europepmc.org/articles/PMC7428320
Autor:
Bartolome Burguera, Michael W. Kattan, Anita D. Misra-Hebert, Arshiya Mariam, Neeraj N. Iyer, Abhilasha Ramasamy, Galen Miller-Atkins, Janine Bauman, Robert S. Zimmerman, Todd Hobbs, Alex Milinovich, Michelle Mocarski, Kevin M. Pantalone, B. Gabriel Smolarz, Daniel M. Rotroff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fca48909c60ec73e2d3905fbd65a083
https://doi.org/10.1111/dom.14538/v2/response1
https://doi.org/10.1111/dom.14538/v2/response1
Autor:
Jingsong Lu, B. Gabriel Smolarz, Swapna Karkare, Moshe Fridman, Neeraj N. Iyer, Mitch DeKoven, Tam Dang-Tan
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 25:658-668
Previous studies report weight loss to be associated with significantly lower total health care costs among patients with type 2 diabetes mellitus (T2DM). The effect of weight change on health care costs, independent of glycemic control and after con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e3704be4bc5f42a882285092d34bc4f
https://doi.org/10.18553/jmcp.2019.18321
https://doi.org/10.18553/jmcp.2019.18321
Publikováno v:
Diabetes Therapy
Introduction Improving real-world medication adherence to injectable antihyperglycemics in type 2 diabetes mellitus (T2DM) is a clinical challenge. Quantification of the level of adherence required to achieve a minimal clinically important difference
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::382f9968b02c08f41a7c54e7a3fec1ba
http://europepmc.org/articles/PMC6531561
http://europepmc.org/articles/PMC6531561
Publikováno v:
Diabetes spectrum : a publication of the American Diabetes Association. 34(2)
OBJECTIVE Despite the demonstrated benefits of glucagon-like peptide 1 (GLP-1) receptor agonist therapy, adherence and persistence with this therapy is often challenging. The purpose of this study was to expand current understanding of patients’ ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3506d698c5d60f211dab5a3ac7a1c4a5
https://pubmed.ncbi.nlm.nih.gov/34149258
https://pubmed.ncbi.nlm.nih.gov/34149258